Journal of Turkish Clinical Biochemistry

The official publication of Turkish Society of Clinical Biochemistry

Diamond OA
No APCs
First Decision
30 Days
Indexed In
TR Dizin
Original Research
April 01, 2004
JTCB. 2004 Apr 1; 2 (1) : 009-016

The Evaluation of Specific Proteins in Patients with Diabetic Nephropathy

1 Atatürk Eğitim ve Araştırma Hastanesi, II. Biyokimya ve Klinik Biyokimya Laboratuvarı, İzmir
2 Celal Bayar Üniversitesi Tıp Fakültesi, Endokrinoloji Bilim Dalı, Manisa

Abstract

Introduction: Diabetic nephropathy is the most common cause of end stage renal disease. Early diagnosis of diabetic nephropathy is essential for prevention progression to end stage renal disease.

Aim: The aim of this study was to evaluate the association of specific proteins such as transferrin, ceruloplasmin, alpha-2-macroglobulin, alpha-1-antitrypsin, IgG, IgM, beta-2-microglobulin with glycemic control and to investigate the usefulness of using these markers in early diagnosis of nephropathy in subjects nephropathy developed or not in type II diabetic patients.

Materials and Methods: 34 Type 2 Diabetes Mellitus (DM) patients with diabetic nephropathy and 58 Type2 DM patients without complications were included in this study.

Results: Serum TRF levels of macroalbuminuria group were significantly lower (p<0.05), however serum α1-antitrypsin (A1AT), serum and urine B2MG, microalbumin levels were higher than normoalbuminuria group (For all p<0.001). Diabetic nephropathy group had a significant inverse correlation between serum B2MG and fructosamine (r=-0.739, p=0.023).

Conclusion: In conclusion, it was found that there was a decline in TRF level and elevations in urinary and serum B2MG levels in Type 2 diabetic patients with macroalbuminuria proportional to degree of nephropathy. It was observed that B2MG levels are related with glicemic control. Moreover, serum A1AT level is also an important predictor in demonstration of the tubular injury and monitorization of nephropathy independently from glycemic control.

Citation

Çalışkaner, Polat, Ayşenur Atay, Mehmet H. Köseoğlu, and Zeliha Hekimsoy. 2004. “The Evaluation of Specific Proteins in Patients With Diabetic Nephropathy”. Journal of Turkish Clinical Biochemistry 2 (1):009-016. https://turkclinbiochem.org/index.php/pub/article/view/24.

Publish with JTCB

Diamond Open Access

Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.

30-Day First Decision

Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.

Global Platform

Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.

Focused Laboratory Scope

Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.

Credible and Discoverable

All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.